All Stories

  1. Tumor Board: Decision-making in high-grade endometrial carcinoma when fertility preservation is not feasible.
  2. Neoadjuvant chemotherapy followed by interval surgery versus primary debulking surgery in FIGO stage III–IV epithelial ovarian cancer: A systematic review and meta-analysis
  3. Navigating the Landscape of Resistance Mechanisms in Antibody–Drug Conjugates for Cancer Treatment
  4. Survival after interval and delayed cytoreduction surgery in advanced ovarian cancer: a Global Gynaecological Oncology Surgical Outcomes Collaborative–Led Study (GO SOAR2)
  5. WRN dependency in dMMR/MSI-H endometrial cancer: Clinical perspectives of a novel synthetic lethality strategy
  6. Evaluating The Impact Of Carbon Ion Radiotherapy In Unresectable Female Genital Tract Melanomas: Insights From A Preliminary Real-World Study
  7. Morbidity And Complication Of Minimally Invasive Staging For Apparent Early-Stage Epithelial Ovarian Cancer: A Preliminary Analysis Of REMISSION Study
  8. Robotic Surgery from a Gynaecological Oncology Perspective: A Global Gynaecological Oncology Surgical Outcomes Collaborative Led Study (GO SOAR3)
  9. Investigating the Local Effectiveness of Carbon Ion Radiotherapy for Unresectable Female Genital Tract Melanomas: A Preliminary Real-World Study
  10. Fertility-sparing treatment with conization versus radical hysterectomy in patients with early-stage cervical cancer: inverse propensity score weighted analysis
  11. Pelvic Neuro-Visualization: An Anatomical Illustration of the Autonomic Pelvic Nervous Network in Gynecologic Surgery
  12. Sentinel lymph node pathological ultrastaging: Final outcome of the Sentix prospective international study in patients with early-stage cervical cancer
  13. A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts
  14. Are biomarkers expression and clinical-pathological factors predictive markers of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer?
  15. European Society of Gynaecological Oncology expanded quality indicators and accreditation for cervical cancer management
  16. Endometriosis-associated ovarian cancer: a different clinical entity
  17. Editorial: New strategies to overcome platinum resistance in ovarian cancer
  18. Sentinel lymph node biopsy in endometrial cancer: When, how and in which patients
  19. Burnout among surgeons before and during the SARS-CoV-2 pandemic: an international survey
  20. International Variations in Surgical Morbidity and Mortality Post Gynaecological Oncology Surgery: A Global Gynaecological Oncology Surgical Outcomes Collaborative Led Study (GO SOAR1)
  21. Real-time Fluorescent ICG and 99m-Tc Nanocolloid Tracer Navigation in Bilateral Sentinel Lymph Node Mapping of Vulvar Cancer
  22. #184 An instagram analysis of current discussions and trends in cervical cancer: findings from the european network of young gynecologic oncologists (ENYGO) study
  23. #188 Gynaecologic cancer conversations on instagram: a study by the european network of young gynaecologic oncologists (ENYGO) investigating current trends and discussions
  24. Low pressure laparoscopic procedure in morbidly obese patients with endometrial carcinoma using a new subcutaneous abdominal wall-retraction device: a surgical challenge
  25. Social media ambassadors and collaboration with OncoAlert: a European Network of Young Gynae Oncologists study of comparative Twitter analysis of #ESGO2021 and #ESGO2022
  26. Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries
  27. Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTIlity Sparing Surgery retrospective multicenter study
  28. Diagnostic Accuracy of Magnetic Resonance Imaging in the Pre-Operative Staging of Cervical Cancer Patients Who Underwent Neoadjuvant Treatment: A Clinical–Surgical–Pathologic Comparison
  29. Lymphatic mapping and sentinel node biopsy in vulvar melanoma: the first multicenter study and systematic review
  30. The neglected role of preimplantation genetic testing for Lynch syndrome
  31. Response to treatment and prognostic significance of supradiaphragmatic disease in patients with high-grade serous ovarian cancer
  32. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries
  33. Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study
  34. 2022-RA-959-ESGO Pelvic sentinel lymph nodedistribution; the final outcome of the Sentix trial (CEEGOG-CX01; ENGOT-CX2; NCT02494063)
  35. 2022-RA-908-ESGO The importance of pathological ultrastaging for sentinel lymph nodebiopsy in cervical cancer, the final outcome of the Sentix study (CEEGOG-CX01; ENGOT-CX2; NCT02494063)
  36. Editorial: Molecular influences in therapies in ovarian cancer
  37. Editorial: Future Perspectives of Sentinel Node Mapping in Gynecological Oncology
  38. Uterine serous carcinoma: role of surgery, risk factors and oncologic outcomes. Experience of a tertiary center
  39. Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessment
  40. Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic
  41. Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
  42. Fertility preservation in women with peritoneal surface malignancies: A case series
  43. EPV119/#397 Volume of nodal disease and oncologic outcomes in endometrial cancer patients with positive sentinel lymph nodes: an Italian multi-institutional study
  44. Fertility-Sparing Treatment of Patients with Endometrial Cancer: A Review of the Literature
  45. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
  46. 950 Sensitivity and false negativity of SLN frozen sectionhistological evaluation in the sentix trial (CEEGOG-CX01; ENGOT-CX2; NCT02494063)
  47. 252 Type of sentinel lymph nodes metastases and oncologic outcomes in endometrial cancer patients: an italian multi-institutional study
  48. Determining post-operative morbidity and mortality following gynecological oncology surgery: protocol for a multicenter, international, prospective cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative—GO SOAR)
  49. SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study
  50. Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study
  51. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score
  52. Using rADioMIcs and machine learning with ultrasonography for the differential diagnosis of myometRiAL tumors (the ADMIRAL pilot study). Radiomics and differential diagnosis of myometrial tumors
  53. Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study
  54. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
  55. Correction to: Oocyte cryopreservation in two women with borderline ovarian tumor recurrence
  56. Timing of surgery following SARS-CoV-2 infection
  57. Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer
  58. Conization and lymph node evaluation as a fertility-sparing treatment for early stage cervical cancer
  59. Corrigendum to “Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group” [European Journal...
  60. Oncological outcomes of laparoscopic radical hysterectomy versus radical abdominal hysterectomy in patients with early-stage cervical cancer: a multicenter analysis
  61. Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
  62. 558 Fertility-sparing treatment for early stage cervical cancer: a single center experience with conization and nodal evaluation
  63. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic
  64. Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group
  65. Fertility preservation in women with cervical cancer
  66. Delaying surgery for patients with a previous SARS-CoV-2 infection
  67. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
  68. Change in practice in gynecologic oncology during the COVID-19 pandemic: a social media survey
  69. Central Pathology Review in SENTIX, a Prospective Observational International Study on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (ENGOT-CX2)
  70. Oocyte cryopreservation in two women with borderline ovarian tumor recurrence.
  71. The role of Hysteroscopy in endometrial cancer sentinel node mapping
  72. Corrigendum to “Advances in laparoscopic surgery for cervical cancer” [Crit. Rev. Oncol. Hematol. 143 (August) (2019) 76–80]
  73. Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women
  74. Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups
  75. Sentinel Node Mapping in Endometrial Cancer
  76. Advances in laparoscopic surgery for cervical cancer
  77. EP571 Sentinel node mapping in endometrial cancer: analysis of more than 200 cases of hysteroscopic injection of tracers
  78. EP481 Sentinel node mapping vs. lymphadenectomy in endometrial cancer: a systematic review and meta-analysis
  79. Re: Concordance Between Intracervical and Fundal Injections for Sentinel Node Mapping in Patients With Endometrial Cancer? A Study Using Intracervical Radiotracer and Fundal Blue Dye Injections
  80. Nomogram-based prediction of cervical dysplasia persistence/recurrence
  81. 165 A retrospective study showing the safety of minimally invasive surgery of cervical cancer
  82. Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer
  83. Long-term results of fertility-sparing treatment for early-stage cervical cancer
  84. Oncological outcome of surgical management in patients with recurrent uterine cancer—a multicenter retrospective cohort study—CEEGOG EX01 Trial
  85. Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence
  86. Predictive factors of recurrence in patients with early‐stage epithelial ovarian cancer
  87. Minimally invasive surgery improves short-term outcomes of nerve-sparing radical hysterectomy in patients with cervical cancer: a propensity-matched analysis with open abdominal surgery
  88. Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study
  89. Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved
  90. Investigating the Role of Minimally Invasive Radical Hysterectomy in Cervical Cancer
  91. Rectus Abdominis Myofascial Flap for Vaginal Reconstruction After Pelvic Exenteration
  92. Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC–IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional Study
  93. New prophylactics human papilloma virus (HPV) vaccines against cervical cancer
  94. Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence
  95. The addition of lymphadenectomy to secondary cytoreductive surgery in comparison with bulky node resection in patients with recurrent ovarian cancer
  96. Neoadjuvant chemotherapy followed by interval debulking surgery for unresectable stage IVB Serous endometrial cancer
  97. Potential impact of introducing a nonavalent HPV vaccination
  98. Factors Predictive of 90-Day Morbidity, Readmission, and Costs in Patients Undergoing Pelvic Exenteration
  99. Role of bevacizumab in uterine leiomyosarcoma
  100. Ovarian preservation in locally advanced cervical cancer undergoing neoadjuvant chemotherapy and radical surgery
  101. Dose dense neoadjuvant chemotherapy (NACT) with carboplatin-paclitaxel in locally advanced cervical cancer.
  102. Evaluation of capecitabine in patients with platinum-pretreated advanced or recurrent cervical carcinoma: A retrospective study of the IRCCS National Cancer Institute of Milan.
  103. LASER treatment for women with high-grade vaginal intraepithelial neoplasia: A propensity-matched analysis on the efficacy of ablative versus excisional procedures
  104. Predicting Factors for High-Grade Cervical Dysplasia in Women With Low-Grade Cervical Cytology and Nonvisible Squamocolumnar Junction
  105. The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment
  106. A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
  107. Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer
  108. Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer
  109. The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer
  110. Locally Advanced Cervical Cancer: Is a Trimodality Treatment a Safe and Effective Approach?
  111. Nerve-Sparing Approach Improves Outcomes of Patients Undergoing Minimally Invasive Radical Hysterectomy: A Systematic Review and Meta-Analysis
  112. Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?
  113. Regarding “The Role of Routine Peritoneal and Omental Biopsies at Risk-reducing Salpingo-oophorectomy”
  114. Introducing nerve-sparing approach during minimally invasive radical hysterectomy for locally-advanced cervical cancer: A multi-institutional experience
  115. The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC–IV Unresectable Ovarian Cancer
  116. Subjective Ultrasound Assessment and the Adnex Model to Differentiate between Benign and Malignant Ovarian Tumors
  117. SENTINEL NODE MAPPING IN ENDOMETRIAL CANCER: A SINGLE CENTER EXPERIENCE OVER 200 CASES OF HYSTEROSCOPIC INJECTION OF TRACERS
  118. POTENTIAL CLINICAL IMPACT OF THE INTRODUCTION OF THE NONAVALENT HUMAN PAPILLOMAVIRUS VACCINATION: AN ANALYSIS OF 13,665 PATIENTS OVER A 18-YEAR STUDY PERIOD
  119. ASSESSING THE RISK OCCULT CANCERS AND 30-DAY MORBIDITY IN BRCANESS WOMEN UNDERGOING RISK-REDUCING SURGERY: A PREDICTIVE MODEL AND NOMOGRAM
  120. FACTORS PREDICTIVE OF 30-DAY MORBIDITY, READMISSION AND COSTS IN PATIENTS UNDERGOING PELVIC EXENTERATION
  121. Invasive Paget Disease of the Vulva
  122. Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses
  123. Phase II study of the safety and efficacy of oral capecitabine in patients with platinum-pretreated advanced or recurrent cervical carcinoma
  124. The impact of chemotherapy-related leukopenia on survival outcomes in locally advanced cervical cancer
  125. Lymphnode evaluation with SLN procedure after peritumoral injection of tracer with hysteroscopy
  126. Safety and effectiveness of Human Papillomavirus (HPV) vaccination: NCI of Milan position statement
  127. Implementation of Extensive Cytoreduction Resulted in Improved Survival Outcomes for Patients with Newly Diagnosed Advanced-Stage Ovarian, Tubal, and Peritoneal Cancers
  128. Selecting patients for Laparoscopic interval debulking surgey (IDS) in ovarian cancer
  129. Interpregnancy Interval and Adverse Pregnancy Outcomes
  130. Treatment of Genital Melanoma
  131. Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience
  132. Impact of Surgical Route in Influencing the Risk of Lymphatic Complications After Ovarian Cancer Staging
  133. The safety of antiangiogenic agents and PARP inhibitors in platinum-sensitive recurrent ovarian cancer
  134. Long-acting recombinant follicle-stimulating hormone in random-start ovarian stimulation protocols for fertility preservation in women with cancer
  135. Minimally Invasive Surgical Staging in Early-stage Ovarian Carcinoma: A Systematic Review and Meta-analysis
  136. Sentinel-lymph-node mapping in endometrial cancer
  137. Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy
  138. Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology
  139. The association of pre-treatment HPV subtypes with recurrence of VIN
  140. Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasia
  141. Accuracy of pre-operative hysteroscopic guided biopsy for predicting final pathology in uterine malignancies
  142. Impact of Blood Transfusions on Survival of Locally Advanced Cervical Cancer Patients Undergoing Neoadjuvant Chemotherapy Plus Radical Surgery
  143. Type-specific HPV infection correlates with risk of recurrence of vulvar intraepithelial neoplasia usual type
  144. Sentinel node techinique in endometrial cancer
  145. Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer
  146. Minimally Invasive Surgical Staging for Ovarian Carcinoma: A Propensity-Matched Comparison With Traditional Open Surgery
  147. Bulky Mesonephric Adenocarcinoma of the Uterine Cervix Treated with Neoadjuvant Chemotherapy and Radical Surgery: Report of the First Case
  148. Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: A systematic review and meta-analysis
  149. 16th Biennial Meeting of the International Gynecologic Cancer Society
  150. Fertility preservation in women with borderline ovarian tumours
  151. Surgical Management and Prognostic Factors of Vulvovaginal Melanoma
  152. Incorporating 3D Laparoscopy for the Management of Locally Advanced Cervical Cancer: A Comparison with Open Surgery
  153. Is aortic lymphadenectomy indicated in locally advanced cervical cancer after neoadjuvant chemotherapy followed by radical surgery? A retrospective study on 261 women
  154. Morcellator's Port-site Metastasis of a Uterine Smooth Muscle Tumor of Uncertain Malignant Potential After Minimally Invasive Myomectomy
  155. Extraperitoneal Robotic-Assisted Para-Aortic Lymphadenectomy in Gynecologic Cancer Staging: Current Evidence
  156. 3D Vision Improves Outcomes in Early Cervical Cancer Treated with Laparoscopic Type B Radical Hysterectomy and Pelvic Lymphadenectomy
  157. Surgical Techniques for Diaphragmatic Resection During Cytoreduction in Advanced or Recurrent Ovarian Carcinoma
  158. Morcellation of undiagnosed uterine sarcoma: A critical review
  159. FDG-PET/CT to Predict Optimal Primary Cytoreductive Surgery in Patients with Advanced Ovarian Cancer: Preliminary Results
  160. Adult-Onset Cervical Embryonal Rhabdomyosarcoma and DICER1 Mutations
  161. Reply to A Buda
  162. Don't forget the uterus while preserving fertility
  163. Morcellation of apparent benign uterine myoma: assessing risk to benefit ratio
  164. Fertility Sparing Options in Gynecologic Oncology
  165. Abstract B157: OX40 expression in tumor-associated Tregs as a potential prognostic biomarker and immunotherapeutic target in ovarian cancer
  166. Pneumoperitoneum pressures during pelvic laparoscopic surgery: a systematic review and meta-analysis
  167. Incidence of port-site hernia following robotic-assisted sacrocolpopexy
  168. Sentinel Node Mapping in Endometrial Cancer By Using Hysteroscopic Injection of Indocyanine Green and Laparoscopic Near-Infrared Fluorescence Imaging: A Preliminary Experience
  169. OC07.05: Application of 3D ultrasound in the assessment of dose-dense NACT efficacy in patients with cervical cancer
  170. When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer
  171. Time for a less radical surgery in cervical cancer after neoadjuvant chemotherapy?
  172. Peritoneal cytology as prognostic factor in cervical cancer
  173. Long-term safety of fertility sparing surgery in early stage ovarian cancer: Comparison to standard radical surgical procedures
  174. OX40 expression in tumor-associated Tregs as a potential prognostic biomarker and immunotherapeutic target in ovarian cancer.
  175. Surgical Treatment of Recurrent Endometrial Cancer: Time for a Paradigm Shift
  176. Fertility-Sparing Surgery in Early-Stage Cervical Cancer Patients
  177. Sentinel Node Mapping Using Hysteroscopic Injection of Indocyanine Green and Laparoscopic Near-Infrared Fluorescence Imaging in Endometrial Cancer Staging
  178. Implementation of laparoscopic approach for type B radical hysterectomy: A comparison with open surgical operations
  179. Treatment of Early Ovarian Cancer
  180. A critical assessment on the role of sentinel node mapping in endometrial cancer
  181. Fertility-sparing surgery in high-risk ovarian cancer
  182. Carboplatin-Paclitaxel Versus Cisplatin-Ifosfamide in the Treatment of Uterine Carcinosarcoma
  183. Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation
  184. Class II versus Class III radical hysterectomy in early cervical cancer: An observational study in a tertiary center
  185. Phase II prospective study on trabectedin (T) in BRCA-mutated and BRCAness phenotype advanced ovarian cancer (AOC) patients (pts): The MITO 15 trial.
  186. Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
  187. Fertility sparing surgery in early stage epithelial ovarian cancer
  188. Role of paclitaxel and cisplatin as the neoadjuvant treatment for locally advanced squamous cell carcinoma of the vulva
  189. Embryonal Rhabdomyosarcoma of the Uterine Cervix in Adults
  190. Radical Abdominal Hysterectomy Type B
  191. Photodynamic therapy with M-ALA as non surgical treatment option in patients with primary extramammary Paget's disease
  192. The Role of Lymphadenectomy in Cervical Cancer Patients: The Significance of the Number and the Status of Lymph Nodes Removed in 526 Cases Treated in a Single Institution
  193. Advanced ovarian cancer: Omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumor
  194. Laparoscopic Versus Open Radical Hysterectomy for Stage IB2–IIB Cervical Cancer in the Setting of Neoadjuvant Chemotherapy: A Multi-institutional Cohort Study
  195. Utility of Conization With Frozen Section for Intraoperative Triage Prior to Definitive Hysterectomy
  196. Frozen cone to decide between simple or radical hysterectomy
  197. Diagnostic accuracy of sentinel node in endometrial cancer by using hysteroscopic injection of radiolabeled tracer
  198. Systematic Para-aortic and Pelvic Lymphadenectomy in Early Stage Epithelial Ovarian Cancer: A Prospective Study
  199. Third-line chemotherapy with tyrosine kinase inhibitor (imatinib mesylate) in recurrent ovarian granulosa cell tumor: Case report
  200. Class III Nerve-sparing Radical Hysterectomy Versus Standard Class III Radical Hysterectomy: An Observational Study
  201. Class III NSRH: Oncological outcome in 170 cervical cancer patients
  202. Sentinel Node Detection in Endometrial Cancer. Diagnostic Accuracy Evaluation
  203. Quality of Life and Sexual, Bladder, and Intestinal Dysfunctions After Class III Nerve-Sparing and Class II Radical Hysterectomies
  204. Nerve-Sparing Radical Vaginectomy
  205. Weekly topotecan and cisplatin (TOPOCIS) as neoajuvant chemotherapy for locally-advanced squamous cervical carcinoma: results of a phase II study
  206. Hysteroscopy in endometrial cancer: new methods to evaluate transtubal leakage of saline distension medium
  207. Nerve-sparing radical hysterectomy in cervical cancer: Evolution of concepts
  208. Incidental Diagnosis of Primary Vaginal Adenocarcinoma of Intestinal Type
  209. Surgical Treatment in FIGO Stage I Cervical Cancer: Evolution of Concepts
  210. Angiokeratoma corporis diffusum (Anderson-Fabry's disease): a case report